pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
PFIZER · news · pharmadog
← back to PFIZER
News mentioning PFIZER
392
stories
Jul 15, 26
Merck ADC, in China study, shows potential to replace chemo in lung cancer
biopharma dive
Jul 15, 26
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
biopharma dive
Jul 13, 26
Agenus surges on study pivot; Apnimed lines up an IPO
biopharma dive
Jul 10, 26
Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustments
endpoints
Jul 9, 26
AstraZeneca, Ionis drug fails big heart disease study in major setback
biopharma dive
Jul 8, 26
STAT+: Europe will accelerate its review of RevMed’s drug
stat
Jul 8, 26
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
stat
Jul 7, 26
Kailera says obesity pill succeeds in late-stage trial in China
biopharma dive
Jul 7, 26
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
biopharma dive
Jul 2, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Jul 1, 26
FDA says Zyn can market its pouches as safer than cigarettes
stat
Jun 30, 26
Beeline ups its Series A round for immune drug work
biopharma dive
Jun 30, 26
House China panel probes Bristol Myers, Pfizer on use of trial sites
endpoints
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 26, 26
At BIO, tension over China biotech deal regulation looms
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 18, 26
Pfizer CFO to step down; Denali sells a regulatory fast-pass
biopharma dive
Jun 18, 26
Pfizer CFO to depart; GSK wins approval for UTI drug
endpoints
Jun 18, 26
What’s next for GLP-1 weight loss drugs?
stat
Jun 17, 26
STAT+: Advocacy groups petition FDA to withdraw approval of ‘unsafe’ use of antibiotics given to livestock
stat
Jun 17, 26
STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and more
stat
Jun 17, 26
STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far?
stat
Jun 16, 26
STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
stat
Jun 15, 26
STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada
stat
Jun 15, 26
STAT+: A key European clinical trial registry lacks complete and timely results, an analysis finds
stat
Jun 15, 26
STAT+: Lilly’s Ajax acquisition may have been worth it
stat
Jun 15, 26
STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more
stat
Jun 15, 26
STAT+: One California politician’s unexpected crusade against ultra-processed food
stat
Jun 15, 26
STAT+: Amid confusion over Pfizer’s emergency penicillin program, newborn is diagnosed with preventable syphilis
stat
Jun 12, 26
STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
stat
← prev
page 10 of 14
next →